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Abstract. Emerging evidence suggests that both apoptosis and
autophagy contribute to global cerebral ischemia‑reperfusion
(GCIR)‑induced neuronal death, which results from cardiac
arrest (CA). However, the mechanism of how GCIR may
affect the balance between apoptosis and autophagy resulting
from CA remains to be elucidated. Additionally, the role of
adiponectin (APN) in reversing the apoptosis and autophagy
induced by GCIR following cardiac arrest‑cardiopulmonary
resuscitation (CA‑CPR) is unclear. Thus, the aim of the present
study was to investigate how GCIR affect the apoptosis and
autophagy in response to CA and to clarify whether APN
may alter the apoptosis and autophagy of neuronal death in
GCIR‑injured brain post‑CA‑CPR. Using normal controls
(Sham group) and two experimental groups [CA‑CPR‑induced
GCIR injury (PCAS) group and exogenous treatment with
adiponectin post‑CA‑CPR (APN group)], it was demonstrated
that both apoptosis and autophagy were observed simultaneously in the brain subjected to GCIR, but apoptosis appeared
to be more apparent. Exogenous administration of APN
significantly reduced the formation of malondialdehyde, a
marker of oxidative stress and increased the expression of
superoxide dismutase, an anti‑oxidative enzyme, resulting
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in the stimulation of autophagy, inhibition of apoptosis and
reduced brain tissue injury (P<0.05 vs. PCAS). APN treatment
increased the expression of APN receptor 1 (AdipR1) and the
phosphorylation of AMP‑activated protein kinase (AMPK;
Ser182) in brain tissues. In conclusion, GCIR induced apoptosis and inhibited autophagy, contributing to brain injury
in CA‑CPR. By contrast, APN reduced the brain injury by
reversing the changes of neuronal autophagy and apoptosis
induced by GCIR. The possible mechanism might owe to
its effects on the activation of AMPK after combining with
AdipR1 on neurons, which suggests a novel intervention
against GCIR injury in CA‑CPR conditions.
Introduction
Although improved cardio‑pulmonary resuscitation (CPR)
strategies have increased the return of spontaneous circulation
(ROSC) rate in cardiac arrest (CA) patients, both the discharge
survival rate and long‑term prognosis of these patients remain
poor (1). Global cerebral ischemia‑reperfusion (GCIR) injury
has been considered as one of the most important contributions
to poor prognosis (2). However, the exact mechanisms leading
to exacerbated post‑GCIR remodeling and poor outcomes in
ROSC patients are incompletely understood, and effective
therapeutic interventions are limited (3).
Emerging evidence suggests that both apoptosis and
autophagy contribute to GCIR‑induced neuronal death
resulting from CA (4). Numerous studies have demonstrated
that oxidative stress occurs during focal cerebral ischemia‑
reperfusion promoting protein oxidation, which could
impair neuron protein synthesis and metabolism resulting in
inevitable neuron apoptosis (5‑7). However, definitive proof
of the cause‑and‑effect relationship between oxidative stress
and neuron apoptosis following CA‑CPR‑induced GCIR has
remained elusive.
Autophagy is an evolutionarily conserved stress‑response
mechanism, which often occurs in ischemia‑reperfusion
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(IR)‑induced oxidative stress (8). Several studies indicated that
switching apoptosis to autophagy protects neurons exposed to
focal cerebral ischemia or GCIR induced by vertebral artery
occlusion (9,10). However, whether the crosstalk between
autophagy and apoptosis affects GCIR injury and improves
the survival and neurological outcomes of ROSC patients
remains to be elucidated, and the mechanisms are unclear (11).
Adiponectin (APN), also known as GBP‑28, apM1,
AdipoQ and Acrp30, is a novel adipokine that maintains
insulin responsiveness, stimulates mitochondrial biogenesis,
inhibits inflammatory response and modulates autophagy
and apoptosis in different disease models (12,13). A clinical
study has revealed that the level of APN is independently
associated with mortality and low plasma APN is related to
an increased risk of 5‑year mortality following the first‑ever
ischemic stroke in humans (14). The preliminary experiment
of the present study demonstrated that APN relieved GCIR by
impairing apoptosis in brain tissues of mice suffering from
CA‑CPR. It has been shown that, APN markedly decreased
neuronal injury and infarct size by inhibiting neuronal apoptosis and alleviating oxidative stress in neurons subjected to
middle cerebral artery occlusion (MACO)‑induced focal cerebral ischemia (FCI) (15). However, few previous studies had
clarified the definitive effects of APN on neuronal apoptosis
and autophagy following GCIR induced by CA‑CPR, and
the underlying mechanisms of these effects remain poorly
understood.
The present study reported that APN relieved the brain
injury via an adiponectin receptor 1 (AdipoR1)/AMP‑activated
protein kinase (AMPK)‑dependent mechanism in a GCIR
mice model induced by CA‑CPR.
Materials and methods
Animals and reagents. In total, 60 adult male C57BL/6
(Chengdu Da Shuo Laboratory Animal Co., Ltd., Chengdu,
Sichuan) mice, at 8 weeks of age (body weight, 30‑35 g), were
bred according to guidelines in compliance with the current
international laws and policies (16). All animal studies were
approved by the Institutional Animal Care and Use Committee
at West China Hospital, Sichuan University (no. 2017071A).
The mice were housed in a conventional facility under
adequate temperature (23˚C) and humidity (60%) conditions
with a 12‑h light/dark cycle and could freely access food and
tap water.
Recombinant mouse APN was provided by Professor
Xinliang Ma of the Thomas Jefferson University (Philadelphia,
USA). Antibodies against cleaved caspase‑3 (cat. no. 9661T,
Rabbit, 1:1,000), Bcl‑2 (cat. no. 3498T, rabbit, 1:1,000), light
chain 3 (LC3) II (cat. no. 3868T, rabbit, 1:1,000), Beclin‑1
(cat. no. 3495T, rabbit, 1:1,000), AMPK (cat. no. 4182; rabbit;
1:1,000), anti‑ β ‑actin (cat. no. 3700; mouse; 1:1,000) and
p‑AMPK (cat. no. 4186, rabbit, 1:1,000) were purchased
from Cell Signaling Technology, Inc. APN receptor 1 (rabbit,
1:1,000) was purchased from Santa Cruz Biotechnology, Inc.
Malondialdehyde (MDA; cat. no. A003‑1) and superoxide
dismutase (SOD; cat. no. A001‑1‑1) detection kits were
purchased from Nanjing Jiancheng Bioengineering Institute.
A mouse APN/Acrp30 Quantikine ELISA kit (MRP300) was
purchased from R&D Systems, Inc. IgG horseradish peroxidase
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(HRP)‑conjugated secondary antibodies were purchased from
Beyotime Institute of Biotechnology (cat. no. A0208; 1:10,000)
or Applygen Technologies, Inc. (1:100,000; cat. no. C1710).
Experimental protocol. Mice were randomized into various
treatment groups using random number table: i) Sham group
(n=20) was subjected to invasive operation and injected with
0.9% saline. The mice experience circulatory arrest for 5 min,
40 successful resuscitated mice were randomly divided into
the PCAS and APN groups, ii) PCAS group (n=20), which
was subjected to cardiac arrest/cardiopulmonary resuscitation (CA/CPR) and injected with 0.9% saline; and iii) APN
group (n=20), which was subjected to CA/CPR and injected
with APN (0.17 mg/kg) as soon as the resuscitation was
successful (15,17,18). Every five mice of each group were
invasively monitored for an additional of 0.5, 3, 6 and 12 h of
reperfusion and were euthanized to harvest the brain tissue
and serum for further measurements.
CA/CPR model. CA/CPR was used to induce global cerebral ischemia in vivo. Mice were anesthetized, which was
maintained with 2% isoflurane, and mechanically ventilated
to maintain respiration using a rodent ventilator (RWD,
Shen Zhen, China). CA/CPR was induced as previously
described (19). A cannula (Fine Science) was inserted into
the right femoral artery to measure arterial blood pressure
(Columbus Instruments). A PE 10 catheter was placed into
the right jugular vein for drug administration. An intubation tube was connected to a ventilator (RWD Life Science)
and mice were ventilated with a tidal volume of 150 µl and
a respiratory rate of 100 bpm. Following all the preparatory
steps, mice were allowed to stabilize for 10 min, during which
blood pressure and temperature were recorded. Cardiac arrest
was induced by transesophageal alternating current (AC)
current stimulation (7 V, 100 Hz) for 180 sec. A pause in AC
stimulation was then initiated for 1‑2 s to observe the change
of electrocardiogram (ECG). As soon as the ventricular fibrillation (VF) reverted spontaneously together with an increase
of blood pressure, additional 30‑sec burst stimulation was
performed until either the VF reappeared and persisted, or
until asystole or pulseless electrical activity (PEA) occurred.
After 2 min with no intervention, cardiopulmonary resuscitation was initiated via an injection of epinephrine (EPI,
0.04 mg/kg, 37˚C; Welman Pharmaceutical Co., Ltd.) into
the jugular vein catheter followed by manual chest compressions and ventilation with 100% oxygen with a tidal volume
of 4 ml/kg and a respiratory rate of 100 bpm. Manual chest
compression at a rate of 200 compressions per minute with
equal compression‑relaxation duration was always performed
by the same investigator who was blinded to the hemodynamic
monitor tracings and guided only by audio tones. Compression
depth was approximately 1/3 of the anteroposterior chest
diameter at maximal compression. ROSC was defined as the
return of ventricular rhythm with a mean aortic pressure of
≥20 mmHg for a minimum of 5 min (20). When there was
a failure to restore spontaneous circulation after 10 min,
resuscitation efforts were discontinued. The flow chart of the
experimental protocol is given in Fig. 1.
The procedure described above was similar for the
CA/CPR and sham animals, except that the control animals
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Figure 1. Flow chart of the experimental protocol. The bottom line indicates cumulative elapsed time. The top line indicates elapsed mean intervals until the
start of each intervention. AC, alternating current; ECG, electrocardiogram; VF, ventricular fibrillation; CPR, cardiopulmonary resuscitation; ROSC, Return
of spontaneous circulation; ', minute.

were injected with isotonic saline instead of epinephrine and
did not experience chest compressions.
Tissue processing. The brain tissue was harvested, followed
by post‑fixing in the 4% paraformaldehyde overnight
at room temperature or homogenizing with lysis buffer
(cat. no. P0013B; Beyotime Institute of Biotechnology). The
homogenized supernatants and serums were stored in ‑80˚C
for western blot analysis and biochemistry indexes.
Histology. Tissue sections were stained with hematoxylin and
eosin (H&E), following standard protocols (21). Briefly, the
mice were sacrificed and intracardially perfused with 1% PBS,
followed by 4% paraformaldehyde overnight at room temperature and were paraffin‑embedded. Then, the tissues were cut
at the thickness of 5 µm, and stained using the hematoxylin
and eosin (HE) via standard processes at room temperature
for 4‑10 min. The images were captured using the upright light
microscope, according to the previous study described (21).
TUNEL assay. TUNEL staining was used to evaluate the
apoptosis of neurons. The brain tissues were fixed with 4%
paraformaldehyde for 12 h at room temperature, paraffin‑
embedded and cut into 5‑µm sections for the TUNEL staining
by using the in situ Apoptosis Detection kit (Roche Diagnostics).
Cxylene was used to de‑paraffinize the paraffin‑embedded
brain tissues for 20 min, and ethanol (75, 85, 95 and 100% for
3 min) series were used to rehydrate the brain tissues. The brain
tissues were incubated with the proteinase K (at final concentration of 20 µg/ml in 10 mM Tris/HCl) at 37˚C for 30 min.
The endogenous peroxidase activity was blocked with 0.3%
H2O2 in methanol for 10 min at room temperature. The cerebral cortex slices were permeabilized by using 0.1% sodium
citrate and 0.1% Triton‑X‑100 for 5 min. Then, the slices were
washed three times with PBS for 10 min, and were incubated
using TUNEL reaction mixture at 37˚C for 60 min. The slices
were incubated using a convertor‑POD in humidity chamber
for 30 min at 37˚C. The slices were washed with PBS again
for three times, and the color was developed by using a DAB
substrate solution for 15 min at room temperature. Finally, the
slices were observed using the light microscopy, and cells with
an apoptotic morphology and TUNEL‑staining positive cells
were identified as apoptotic cells (21,22).

Immunofluorescence staining. Immunofluorescence staining
was performed according to a previous study (23). Briefly,
paraffin sections made in the preparation of HE staining, were
deparaffinized, rehydrated and pretreated with an antigen
unmasking solution (Vector Laboratories, Inc.) for 8 min
followed by blocking with peroxidase blocking reagent (Dako;
Agilent Technologies, Inc.) and 3% goat serum (ABC‑Elite kit;
Vector Laboratories, Inc.). The sections were then incubated
overnight with the polyclonal goat anti‑rabbit cleaved‑caspase
3 and LC3II antibody at 4˚C, followed by a biotinylated
anti‑goat secondary antibody (1:100,000; cat. no. C1711;
Applygen Technologies, Inc.) at 4˚C for 30 min. The secondary
antibody solution was discarded and DAPI solution (1 µg/ml)
was applied directly on slides for 5 min at room temperature.
After washing slides three times each for 10 min in 0.05%
TBS‑Tween 20, the slides were incubated with filtered Sudan
Black B solution directly for 30 sec in the dark at room
temperature. A small amount of fluorescent mounting medium
(50‑100 µl; cat. no. BL701A; Biosharp) and a cover slip was
placed over the specimen, avoiding bubbles. Then, clear nail
polish was used to seal the sides of the cover glass to the
slide. A negative control section was always included in which
the primary antibody was substituted by the corresponding
isotype control.
Western blot analysis. Brain tissue was homogenized with
lysis buffer. The homogenates were centrifuged at 1,000 x g
for 10 min at 4˚C. The protein concentration of the supernatant was measured using the Bradford method (5000001,
Bio‑Rad Laboratories, Inc.). Equal amounts of proteins at
20 µg derived from each sample were separated on 10%
SDS‑PAGE gels (Thermo Fisher Scientific, NPO335BOX)
and electroblotted onto polyvinylidene fluoride membranes
(EMD Millipore, IPVH00010). After blocking by 5% milk
for 30 min at room temperature, membranes were incubated
overnight at 4˚C with antibodies against target proteins. The
membranes were probed with HRP‑conjugated secondary
antibodies at room temperature for 1 h. Immunoreactive
protein bands were visualized by using an enhanced chemiluminescence detection system (GE Healthcare Life Sciences)
according to the manufacturer's protocol. Densitometry data
were analyzed with ImageJ 1. 8. 0 (National Institutes of
Health).
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Table I. Comparison of vital signs in each group (means ± standard errors of the mean).
Vital sign
HR (bpm)
MAP (mmHg)

Sham
444.60±33.37
83.00±5.09

PCAS group	APN group
466.0±37.34
82.40±3.91

471.8±18.15
82.26±4.44

P‑value
0.36
0.28

One way analysis of variance followed by the Tukey post hoc test for pairwise comparisons were used to compare the difference between the
3 groups. PCAS, post cardiac arrest syndrome; APN, adiponectin; HR, heart rate; MAP, mean arterial pressure.

Table II. Comparison of HR and MAP for the three group after 30-min reperfusion (means ± standard errors of the mean).
Vital sign
HR (bpm)
MAP (mmHg)

Sham
489.60±25.17
88.00±3.09

PCAS group	APN group
466.50±33.34
70.40±5.91

473.80±18.15
73.26±3.44

P‑value
0.48
0.33

One way analysis of variance followed by the Tukey post hoc test for pairwise comparisons were used to compare the difference between the
3 groups. PCAS, post cardiac arrest syndrome; APN, adiponectin; HR, heart rate; MAP, mean arterial pressure.

SOD and MDA analyses. The tissue level of MDA and
SOD contents was analyzed following the manufacturer's
instructions (Nanjing Jiancheng Bioengineering Institute), as
previously described (24,25). The bicinchoninic acid method
was used to test tissue protein concentration. The content of
MDA was calculated as nmol/mg protein and the activity of
SOD was expressed as U/mg protein.
ELISA analysis. The plasma level of APN was determined
by using an ELISA kit (MRP300) from R&D Systems, Inc.
according to the manufacturer's instructions.
S t a t is t ic a l a n a lys is. Dat a a r e p r esent e d a s t he
means ± standard errors of the mean. All statistical analyses
were performed using IBM SPSS Statistics 19.0 (IBM Corp.).
Differences of the means among the groups were statistically
analyzed with one‑way or two‑way analysis of variance
followed by the Tukey post hoc test for pairwise comparisons (details in the Figure legends). For all statistical tests,
P<0.05 was considered to indicate a statistically significant
difference.
Results
Physiological parameters. The HRs of the groups i, ii and iii
pre‑CA were 444.60±33.37, 466.0±37.34 and 471.8±18.15 bpm,
respectively (P>0.05). MAPs of the 3 groups were 83.00±5.09,
82.40±3.91 and 82.26±4.44 mmHg, respectively (P>0.05;
Table I). In addition, the chest compression manner affected
the HRs and MAPs without significant differences among the
3 groups at 30 min after ROSC (Table II).
APN relieves GCIRI. H&E staining of the cerebral cortex indicated that the PCAS and APN groups appeared to experience
neuronal death at 0.5 h of reperfusion and neuronal activity
apoptosis occurred at 3 and 6 h of reperfusion. Parts of the blood
vessels and the parenchyma mesh shape changed (microscopic

liquefactive necrosis) in the PCAS group, whereas the severity
was significantly reduced in the APN group (Fig. 2).
APN inhibits the GCIR‑induced apoptosis in brain tissues
and modulated the activation of AMPK induced by GCIR. To
further determine whether GCIR induces apoptosis in the brain
tissues, DAB‑mediated TUNEL and immunofluorescence
staining analysis were performed. The results demonstrated
that APN relieved the apoptosis after 0.5 to 12 h of reperfusion
(Fig. 3A and B).
GCIR significantly induced the expression of apoptotic
protein cleaved caspase‑3 in the brain tissues at all time points
following reperfusion in the PCAS group compared to the
Sham group (P<0.05). Conversely, APN post‑treatment significantly inhibited the induction of cleaved caspase‑3 expression
by GCIR and nearly reversed it to the normal level (P<0.05;
Fig. 3C and D).
The anti‑apoptotic protein, Bcl‑2, increased instantly
following the initiation of GCIR, which seemed to be significantly higher than the Sham group at 0.5 and 3 h of reperfusion
(Fig. 3E). APN post‑treatment increased the expression of
Bcl‑2 induced by GCIR from 3 to 12 h (P<0.05; Fig. 3C and E).
Chen et al (26) demonstrated that UVB radiation
impairs the autophagy response via the phosphorylation of
AMPK at the site of Ser182, as well as stimulating reactive
oxidative stress in keratinocytes. To determine the effects
of GCIR on AMPK activation in brain tissue, the p‑AMPK
(Ser182)/AMPK ratio was measured. The results indicated that
GCIR significantly activated AMPK signaling with a significant elevation of p‑AMPK (Ser182)/AMPK ratio at early as
0.5 h of reperfusion (P<0.05). However, this effect was later
inhibited, especially at 6 and 12 h of reperfusion (P>0.05). In
contrast, APN post‑treatment activated AMPK signaling from
3 h of reperfusion (P<0.05; Fig. 3C and F).
APN irrigates GCIR‑induced autophagy in brain tissues.
LC3II was significantly increased in the GCIR‑induced brain
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Figure 2. The pathological change of different groups. PCAS and APN group exhibited neuron apoptosis at 0.5 h of reperfusion and neuron cavities occurred
at 3 and 6 h of reperfusion (arrows indicated the apoptotic or necrosis cell). Scale bar, 100 µm. PCAS, post cardiac arrest syndrome; APN, adiponectin.

Figure 3. Adiponectin inhibited GCIR‑induced apoptosis in brain tissues. (A) TUNEL‑positive cells were detected by HRP‑conjugated probes with DAB
staining in brain tissues of different groups; I: Sham group, II: PCAS group, III: APN group, arrows indicate apoptotic cells. (B) Expression of cleaved
casepase‑3 in the cortex of different groups mice at 3 h of reperfusion; I: Sham group, II: PCAS group, III: APN group, arrows indicated the apoptotic
cells. Nuclei were stained by DAPI (blue). Apoptotic protein cleaved casepase‑3, anti‑apoptotic protein Bcl‑2 and activation of AMPK were measured by
western blotting in brain tissues of different groups. (C) The grayscale values of (D) casepase‑3, (E) Bcl‑2 and (F) activation of AMPK in different groups.
Data are presented as means ± standard errors of the mean (n=5 per group). *P<0.05 vs. Sham group. #P<0.05 vs. PCAS group. GCIR, global cerebral
ischemia‑reperfusion; HRP, horseradish peroxidase; DAB, 3,3'‑diaminobenzidine; DAPI, 4',6‑diamidino‑2‑phenylindole; AMPK, AMP‑activated protein
kinase; APN, adiponectin; PCAS, post cardiac arrest syndrome.

tissues with or without APN treatment. APN post‑treatment
increased the LC3II expression in the GCIR‑induced brain
tissues, with the most significant increase occurring at 3 h of
reperfusion (P<0.05; Fig. 4A and B).

In addition, GCIR increased the Beclin‑1 after 0.5 h of
reperfusion, but inhibited it after 3 h of reperfusion (P<0.05),
with no more significant effects on Beclin‑1 in the following
time points of reperfusion. By contrast, administration of APN
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Figure 4. Adiponectin irrigated GCIR‑induced autophagy in brain tissues. LC3 II‑positive cells were detected by immunofluorescence staining in the cortex of
different groups of mice at 3 h of reperfusion (A) I: Sham group, II: PCAS group, III: APN group, arrows indicated the autophagic cells. Nuclei were stained
by DAPI (blue). (B) Effects of adiponectin on GCIR‑induced (C) LC3II and (D) Beclin‑1 expression levels in brain tissues. Data are presented as means ± standard errors of the mean (n=5 per group). *P<0.05 vs. Sham group, #P<0.05 vs. PCAS group. GCIR, global cerebral ischemia‑reperfusion; LC3, light chain 3;
PCAS, post cardiac arrest syndrome; APN, adiponectin.

reversed the effect of GCIR on Beclin‑1, except for the 0.5 h of
reperfusion (Fig. 4C and D).
APN alleviates the GCIR‑induced unbalance of oxidative
and anti‑oxidative stress in brain tissues. GCIR significantly
induced the formation of MDA in brain tissues after 0.5, 6
and 12 h of reperfusion (P<0.05), which was significantly
decreased by the post‑treatment of APN at 0.5, 6 and 12 h of
reperfusion (P<0.05; Fig. 5A).
The anti‑oxidative SOD was stimulated by GCIR at all
time points of reperfusion (P<0.05), peaking at 3 h of reperfusion. Post‑treatment of APN further enhanced the stimulation
of GCIR on SOD formation as early as 0.5 h of reperfusion
(P<0.05), peaking at 3 h of reperfusion (P<0.05; Fig. 5B).
Variation of serum APN level and its receptor expressed in
different groups. GCIR significantly increased the serum APN
level following 3 and 6 h of reperfusion (P<0.05), peaking at 3 h.
APN post‑treatment accelerated the increase of serum APN level
induced by GCIR, with its peak concentration appearing as early
as 0.5 h of reperfusion (P<0.05). However, this effect gradually
disappeared, because the serum APN level decreased to less than
that of the PCAS group from 3 to 12 h of reperfusion (Fig. 6A).

GCIR dramatically influenced the AdipoR1 expression
at different ROSC time points. For example, GCIR slightly
increased its expression at 0.5 h of reperfusion (P>0.05)
and then was it significantly inhibited at 3 h of reperfusion
(P<0.05). However, it significantly increased at 6 h of reperfusion, with levels exceeding those of the Sham group. The
injected exogenous APN inhibited the AdipoR1 at the early
stage of reperfusion (0.5 h; P<0.05). However, this effect
gradually disappeared since the AdipoR1 expression was
significantly higher than that in the PCAS group at 3 and 12 h
of reperfusion (P<0.05; Fig. 6B).
Discussion
Numerous studies have demonstrated that apoptosis was one
of the cell death types in different nervous disease models,
such as subarachnoid hemorrhage (27), stroke (28) and
craniocerebral trauma (29). Our previous findings showed that
neuronal apoptosis also occurred in mice with CA (30). The
results of the present study also demonstrated that the activation of the apoptotic protein caspase 3 and expression of the
anti‑apoptotic protein Bcl‑2 in the PCAS group were increased
at 0.5 h after ROSC. These results confirmed that apoptosis
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Figure 5. Adiponectin alleviated the GCIR‑induce unbalance of oxidative and anti‑oxidative stress in brain tissues. The effects of adiponectin in alleviating the
GCIR‑induce unbalance of (A) MDA and (B) SOD levels in brain tissues. Data are presented as means ± standard errors of the mean (n=5 per group). *P<0.05
vs. Sham group, #P<0.05 vs. PCAS group. GCIR, global cerebral ischemia‑reperfusion; MDA, malondialdehyde; SOD, superoxide dismutase; PCAS, post
cardiac arrest syndrome.

Figure 6. The variation of serum APN level and its receptor expressed in different groups. The variation of (A) serum APN level and (B) its receptor expressed at
0.5, 3, 6 and 12 h of reperfusion in different groups. Representative immunoblots are shown below the quantified data. Data are presented as means ± standard
errors of the mean (n=5 per group). *P<0.05 vs. Sham group, #P<0.05 vs. PCAS group. APN, adiponectin; PCAS, post cardiac arrest syndrome.

is one of the main mechanisms in the mice brain following
GCIR injury induced by CA‑CPR.
APN, an adipocyte‑derived secretory protein, plays an
important role in metabolic (31), anti‑inflammatory (32) and
anti‑oxidative activities (33). A number of studies have reported
that APN also specialized in alleviating myocardial, renal and
pancreatic ischemic reperfusion injury by reducing apoptosis (34‑36). Our previous study indicated that APN reduced
the number of apoptotic activities from neurons following
GCIR induced by CA‑CPR (30). The present study indicated
that APN inhibited the apoptosis by reducing the expression of cleaved caspase‑3 in the mice brain tissue following
GCIR induced by CA‑CPR and promoted the expression of
anti‑apoptotic protein Bcl‑2. These results confirmed the

protective effects of APN on GCIR injury induced by CA‑CPR
by inhibiting apoptosis.
Physiologically, autophagy is a self‑protective mechanism
of the cells, as it helps maintain the functions of cell structures,
which might be damaged by apoptosis (37). However, excessive
autophagy also harms the cells, which also results in tissue
injury (38). Previous studies have reported that both autophagy
and apoptosis are involved in the pathology of cerebral hemorrhage, ischemic stroke and craniocerebral trauma (26‑28).
Liu et al (39) indicates that arousing autophagy relieves the brain
injury by decreasing the apoptotic and necrotic cells. Data in the
present study demonstrated that LC3II, a protein subsequently
recruited to the autophagosomal membranes when autophagy
occurred, promptly increased in the brain tissue from 0.5 to
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12 h after ROSC (P<0.05). By contrast, Beclin‑1, an essential
mediator of autophagosome formation and another marker the
activation of autophagy slightly increased at 0.5 h after ROSC,
but decreased to less than that of the sham group from 3 to 12 h
following reperfusion. These results indicated that GCIR
evoked autophagy. In addition, the different expression trends
of LC3II and Beclin‑1 may result from the interaction between
LC3II and Beclin‑1 (35). A previous study has demonstrated
that activation of LC3I to LC3II inhibits Beclin‑1 dissociation
from the Beclin‑1/Bcl‑2 complex, further reducing the polymerization of phosphatidyl inositol kinase (Vps34/PI3K) and finally
resulting in cell autophagy (39). This could be the reason LC3II
was detected earlier than Beclin‑1 in the present study, a finding
that was in accordance with that of Guo et al (40).
The present study indicated that APN increased the
expression of LC3II and Beclin‑1 in the brain tissue simultaneously with inhibition of caspase‑3 activation. To the
best of the authors' knowledge, the present study is the first
to demonstrate that APN protected the neuron from GCIR
injury‑induced excessive apoptosis following CA‑CPR by
promoting autophagy, although Yue et al (41) reported that
APN increases the expression of LC3II and Beclin‑1 in the
skeletal muscle of diabetic mice to reduce apoptotic cells in a
diabetic mouse model. The mechanisms of how APN regulates
the crosstalk between apoptosis and autophagy in brain tissues
injured by GCIR following CA‑CPR remain to be elucidated.
However, some studies have demonstrated that APN reduces
neuronal apoptosis by reducing reactive oxidative stress in an
ischemic stroke model (15,42,43). In the present study, the data
demonstrated that the APN group had a significantly reduced
MDA content and increased SOD level in the brain tissue
injured by GCIR following CA‑CPR. These results confirmed
that APN reduced apoptosis and enhances autophagy by
relieving oxidative stress in the brain tissue injured by GCIR
following CA‑CPR. The present study demonstrated that APN
inhibited the activation of AMPK (Ser182) in the brain tissue
at the early post‑GCIR period (0.5 h) and then enhanced it
at 3 and 12 h of reperfusion, accompanied by decreased
apoptosis and increased autophagy. Although Chen et al (26)
have demonstrated this hypothesis in keratinocytes in cardiac
and liver cells, no previous studies have suggested that APN
activated AMPK (Ser182) signaling pathway to reduce ROS
induced‑apoptosis to autophagy in GCIR injury induced by
CA‑CPR. Thus, it is concluded that APN may be involved in
the protection of neurons in the brain tissue of post‑ROSC
mice by regulating the activation of AMPK (Ser182), although
other studies have reported the priority activation site being
Thr172 (44,45). To the best of the authors' knowledge, the
present study has been the first to reveal that APN promoted
neuronal autophagy following CA‑CPR by activating AMPK
and relieving oxidative stress as a result of reducing apoptosis
and reducing the brain tissue injury following CA‑CPR. In
accordance with a previous study, the expression trend of
AdipoR1 in the present study was inverse to the concentration of APN, confirming the phenomenon of decreased ligand
resulting in increased receptor expression reactively (46).
There are some limitations in the present study. First, it is
a short term study to explore the acute injury following GCIR.
Therefore, only histological and molecular assessments were
performed and no behavioral assessment was conducted. In
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addition, APN knockout (APN‑KO) mice and AMPK inhibitor
were not used; thus, further investigations on the effects of
APN on the regulation of the crosstalk between apoptosis and
autophagy are necessary.
In conclusion, the current study demonstrated that APN
administration shortly following ROSC inhibits GCIR injury
by reducing apoptosis and increasing autophagy through the
activation of the AdipoR1‑AMPK signaling pathway, which is
therefore important from a translational point of view.
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